Developing a Delta Radiomics Framework for Prostate Cancer Progression Biomarkers in Patients under Active Surveillance: Pilot Study
Dyah Ekashanti Octorina Dewi1, Mohammed R. S. Sunoqrot1, Gabriel Addio Nketiah1, Elise Sandsmark2, Sverre Langørgen2, Helena Bertilsson3, Mattijs Elschot1,2, and Tone Frost Bathen1,2
1Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway, 2Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway, 3Department of Urology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
Identification of progressive lesions over time is important to monitor the prostate cancer progression in active surveillance. Delta Radiomics, computed as the relative changes of features among scans, provides temporal evolution of features that may indicate clinical changes along time periods. This pilot study aims to develop a framework to identify progressive lesions on two long-term scans in prostate T2WI based on Delta-radiomics. The current results show that four Delta-radiomics features from GLDM and Shape feature groups have potentials to identify progressive lesions compared to other selected reproducible features.
This abstract and the presentation materials are available to members only;
a login is required.